Published in Endocr Pract on April 08, 2011
Utility of the U.S. Preventive Services Task Force criteria for diabetes screening. Am J Prev Med (2013) 2.82
National recommendations: Psychosocial management of diabetes in India. Indian J Endocrinol Metab (2013) 2.37
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial. Diabetes Care (2013) 2.33
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract (2015) 2.29
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open (2012) 1.51
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care (2011) 1.36
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes (2015) 1.33
Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Adv Ther (2015) 1.24
Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Popul Health Metr (2014) 1.21
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2012) 1.20
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement. Indian J Endocrinol Metab (2015) 1.18
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study. Cardiovasc Diabetol (2015) 1.17
Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care (2014) 1.11
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol (2015) 1.10
Public health implications of recommendations to individualize glycemic targets in adults with diabetes. Diabetes Care (2012) 1.10
Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLoS One (2013) 1.08
A review of nutritional factors in hypertension management. Int J Hypertens (2013) 1.01
The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups. Adv Ther (2013) 0.98
Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system. Diabetes Technol Ther (2014) 0.98
Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study. Cardiovasc Diabetol (2014) 0.97
Prioritization of care in adults with diabetes and comorbidity. Ann N Y Acad Sci (2011) 0.96
The conductor of the autonomic orchestra. Front Endocrinol (Lausanne) (2012) 0.96
Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes. J Diabetes Investig (2014) 0.93
Temporal trends of hemoglobin A1c testing. J Am Med Inform Assoc (2014) 0.93
The role of incretin therapy at different stages of diabetes. Rev Diabet Stud (2011) 0.89
ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed. J Diabetes Sci Technol (2014) 0.89
Using GIS and secondary data to target diabetes-related public health efforts. Public Health Rep (2013) 0.89
Development and validation of a computer application to aid the physician's decision-making process at the start of and during treatment with insulin in type 2 diabetes: a randomized and controlled trial. J Diabetes Sci Technol (2012) 0.88
Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes. Int J Environ Res Public Health (2014) 0.88
Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iran J Public Health (2014) 0.87
Behavioral and technological interventions targeting glycemic control in a racially/ethnically diverse population: a randomized controlled trial. BMC Public Health (2014) 0.86
Impact of chronic disease self-management programs on type 2 diabetes management in primary care. World J Diabetes (2014) 0.86
Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations. Cardiorenal Med (2013) 0.86
Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best? Drugs Context (2013) 0.86
Metabolic effects of Basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: registry-based observational study in clinical practice. Diabetes Ther (2014) 0.85
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group. Diabetes Technol Ther (2014) 0.85
The impact of diabetes mellitus on patients undergoing degenerative cervical spine surgery. Spine (Phila Pa 1976) (2014) 0.83
Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Lipids Health Dis (2013) 0.83
Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus. Clin Interv Aging (2013) 0.83
Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease. Cardiovasc Diabetol (2012) 0.82
Barriers and Facilitators for Type-2 Diabetes Management in South Asians: A Systematic Review. PLoS One (2015) 0.82
Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD. Cardiovasc Res (2014) 0.81
The design and development of a computer game on insulin injection. Electron Physician (2014) 0.81
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
How Can Diet Affect the Accumulation of Advanced Glycation End-Products in the Human Body? Foods (2016) 0.81
Outcomes and complications of diabetes mellitus on patients undergoing degenerative lumbar spine surgery. Spine (Phila Pa 1976) (2014) 0.81
A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults. PLoS One (2015) 0.80
Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy. Int J Clin Pract (2012) 0.80
Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep (2012) 0.80
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes. Curr Diab Rep (2016) 0.78
Atypical mechanism of glucose modulation by colesevelam in patients with type 2 diabetes. Clin Med Insights Endocrinol Diabetes (2013) 0.78
Psychosocial management of diabetes in pregnancy. Indian J Endocrinol Metab (2013) 0.78
Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus. Acta Diabetol (2015) 0.78
Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions. J Diabetes Sci Technol (2015) 0.78
Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial. J Gen Intern Med (2012) 0.78
Clinical conundrums and challenges during geriatric orthopedic emergency surgeries. Int J Crit Illn Inj Sci (2015) 0.78
Treat-to-target trials in diabetes. Indian J Endocrinol Metab (2014) 0.77
Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain. BMC Endocr Disord (2016) 0.76
Transcultural diabetes nutrition algorithm (tDNA): Venezuelan application. Nutrients (2014) 0.76
Long-term (52-78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients. Diabetes Metab Syndr Obes (2012) 0.76
Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus. Int J Gen Med (2014) 0.76
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain. Ther Clin Risk Manag (2015) 0.75
Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study. Diabetes Ther (2013) 0.75
Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl. Drugs Aging (2012) 0.75
Pharmacological treatment of diabetic peripheral neuropathy. P T (2015) 0.75
Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial. J Diabetes Investig (2016) 0.75
Insulin Use in Pregnancy: An Update. Diabetes Spectr (2016) 0.75
Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes. Drugs Context (2013) 0.75
Use of insulin detemir and insulin glargine during pregnancy: are the data convincing? Endocr Pract (2011) 0.75
The SWEET SPOTS study: a real-world interpretation of the 2012 American Diabetes Association Position Statement regarding individualized A1C targets. Risk Manag Healthc Policy (2016) 0.75
Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial. J Diabetes Investig (2015) 0.75
Critical appraisal of international guidelines for the management of diabetic neuropathy: is there global agreement in the internet era? Int J Endocrinol (2015) 0.75
An Evaluation of the Current Type 2 Diabetes Guidelines: Where They Converge and Diverge. Clin Diabetes (2014) 0.75
Clinical considerations for insulin pharmacotherapy in ambulatory care, part two: review of primary literature and an evidence-based approach for treatment. Clin Diabetes (2015) 0.75
Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome. Bosn J Basic Med Sci (2016) 0.75
The profile of hypertension and dyslipidemia in prediabetic subjects; results of the Isfahan Diabetes Prevention program: A large population-based study. Adv Biomed Res (2015) 0.75
Clinically relevant reductions in HbA1c without hypoglycaemia: results across four studies of saxagliptin. Int J Clin Pract (2013) 0.75
The lower hemoglobin A(1c) value for the screening of prediabetes. Endocr Pract (2011) 0.75
Redesigning the Traditional Community Health Screening Model to Provide Blood Glucose Screening and Interdisciplinary Health Education. Clin Diabetes (2015) 0.75
Cost-analysis of the WHO Essential Medicines List in A Resource-Limited Setting: Experience from A District Hospital in India. J Clin Diagn Res (2014) 0.75
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes. Diabetes Metab Syndr Obes (2014) 0.75
Self-monitoring of blood glucose: one STeP forward? J Diabetes Sci Technol (2012) 0.75
Behavioral Analysis of Chinese Adult Patients with Type 1 Diabetes on Self-monitoring of Blood Glucose. Chin Med J (Engl) (2017) 0.75
Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Diabetol (2017) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet (2009) 9.32
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med (2011) 8.14
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract (2007) 7.55
Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 7.09
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract (2009) 7.06
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res (2004) 5.74
The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care (2003) 5.62
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
Management of diabetes and hyperglycemia in hospitals. Diabetes Care (2004) 5.16
Fast-food consumption among US adults and children: dietary and nutrient intake profile. J Am Diet Assoc (2003) 5.13
Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation (2005) 5.07
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93
AACE comprehensive diabetes management algorithm 2013. Endocr Pract (2013) 4.88
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). Diabetes Care (2009) 4.79
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.78
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28
Recommendations for management of diabetes during Ramadan. Diabetes Care (2005) 4.27
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract (2012) 4.11
Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med (2012) 4.02
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract (2009) 3.96
Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial. Arch Intern Med (2012) 3.95
Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care (2013) 3.89
A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes (2005) 3.84
Rapid microsatellite identification from Illumina paired-end genomic sequencing in two birds and a snake. PLoS One (2012) 3.71
Web-based collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes Care (2008) 3.66
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Care (2007) 3.56
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med (2011) 3.54
Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr (2009) 3.39
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract (2012) 3.29
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation (2003) 3.22
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry (2003) 3.13
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol (2006) 3.11
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2016 EXECUTIVE SUMMARY. Endocr Pract (2016) 3.01
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care (2004) 3.00
Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA (2006) 2.97
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med (2012) 2.90
Sex, race/ethnicity, socioeconomic status, and BMI in relation to self-perception of overweight. Obes Res (2002) 2.87
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid (2012) 2.85
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85